ADHD in the News 2019-08-01

Antipsychotic use in youths with ADHD is low, but still cause for concern

Although fewer young people with ADHD are treated with antipsychotic drugs than suspected, many prescriptions for the drugs do not appear to be clinically warranted, according to a new study from psychiatry researchers at Columbia University Vagelos College of Physicians and Surgeons. They also found that antipsychotic use among youths with ADHD was highest among preschool-age children.

Adult Bipolar Disorder With or Without Childhood ADHD Difficult to Distinguish Using Cognitive Tests

Cognitive testing is limited in its ability to differentiate between adults with bipolar disorder (BD) who had childhood attention-deficit/hyperactivity disorder (ADHD) and those who did not, according to a study published in the International Journal of Bipolar Disorders.

ADHD supplements: Are they effective?

Recently, researchers have been investigating several different supplements that may help alleviate ADHD symptoms. In this article, we outline the research into some of the more promising hormone, dietary, and herbal supplements for ADHD.

How Parents Can Get Kids with ADHD Prepared to Start School

Many preschoolers with attention deficit hyperactivity disorder (ADHD) — or symptoms of it — are much less likely than their peers to be ready for school, a study in Pediatrics found. Experts say, though, that’s no reason to stop the child from entering kindergarten.

Carolyn Hax: Does husband’s job-hopping point to ADHD?

DEAR CAROLYN: My husband just quit his job. Again. Third this year, sixth in four years...Any suggestions?...DEAR ANONYMOUS: A neuropsych screening, if he’ll agree to it...I’m not saying it’s ADHD — layman, not my place — but, an ADHD information site, has a good section on evaluations here that would apply to anyone with a possible neuropsych issue.

ADHD Treatment Adhansia XR Now Available

Adlon Therapeutics announced the launch of Adhansia XR (methylphenidate HCl extended-release capsules) for the treatment of attention deficit hyperactivity disorder (ADHD) in patients aged 6 years and older.

What are the differences between Strattera and Vyvanse?

The Food and Drugs Administration have approved Strattera and Vyvanse to treat attention deficit hyperactivity disorder in children and adults. Strattera (atomoxetine) and Vyvanse (lisdexamfetamine) have different mechanisms of action to treat attention deficit hyperactivity disorder (ADHD). Strattera is a nonstimulant drug while Vyvanse is a stimulant. There are some differences in their side effects, dosages, risks, and drug interactions.

Psychiatrist shortage is a national crisis as need for mental health care grows

A mental health care crisis is gripping our nation. There is still a deeply-rooted stigma around mental illness, but that stigma is slowly starting to crumble. Meanwhile, the demand for psychiatric services is increasing.